 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
GENOPSYS is a privately held company developing proprietary diversity technologies to rapidly optimize novel protein products. Genopsys is focused on commercializing molecules that promise to transform the way disease is detected, treated, and managed in cancer and disorders of the central nervous system.
|
 |
EVENTS October 15 , 2006
|
